Literature DB >> 15067044

Preferential activation of an IL-2 regulatory sequence transgene in TCR gamma delta and NKT cells: subset-specific differences in IL-2 regulation.

Mary A Yui1, Leslie L Sharp, Wendy L Havran, Ellen V Rothenberg.   

Abstract

A transgene with 8.4-kb of regulatory sequence from the murine IL-2 gene drives consistent expression of a green fluorescent protein (GFP) reporter gene in all cell types that normally express IL-2. However, quantitative analysis of this expression shows that different T cell subsets within the same mouse show divergent abilities to express the transgene as compared with endogenous IL-2 genes. TCR gamma delta cells, as well as alpha beta TCR-NKT cells, exhibit higher in vivo transgene expression levels than TCR alpha beta cells. This deviates from patterns of normal IL-2 expression and from expression of an IL-2-GFP knock-in. Peripheral TCR gamma delta cells accumulate GFP RNA faster than endogenous IL-2 RNA upon stimulation, whereas TCR alpha beta cells express more IL-2 than GFP RNA. In TCR gamma delta cells, IL-2-producing cells are a subset of the GFP-expressing cells, whereas in TCR alpha beta cells, endogenous IL-2 is more likely to be expressed without GFP. These results are seen in multiple independent transgenic lines and thus reflect functional properties of the transgene sequences, rather than copy number or integration site effects. The high ratio of GFP: endogenous IL-2 gene expression in transgenic TCR gamma delta cells may be explained by subset-specific IL-2 gene regulatory elements mapping outside of the 8.4-kb transgene regulatory sequence, as well as accelerated kinetics of endogenous IL-2 RNA degradation in TCR gamma delta cells. The high levels and percentages of transgene expression in thymic and splenic TCR gamma delta and NKT cells, as well as skin TCR gamma delta-dendritic epidermal T cells, indicate that the IL-2-GFP-transgenic mice may provide valuable tracers for detecting developmental and activation events in these lineages.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15067044     DOI: 10.4049/jimmunol.172.8.4691

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Stable IL-2 decision making by endogenous c-Fos amounts in peripheral memory T-helper cells.

Authors:  Hanna Bendfeldt; Manuela Benary; Tobias Scheel; Stefan Frischbutter; Anna Abajyan; Andreas Radbruch; Hanspeter Herzel; Ria Baumgrass
Journal:  J Biol Chem       Date:  2012-04-03       Impact factor: 5.157

Review 2.  Role of IL-2 in cancer immunotherapy.

Authors:  Tao Jiang; Caicun Zhou; Shengxiang Ren
Journal:  Oncoimmunology       Date:  2016-04-25       Impact factor: 8.110

Review 3.  The role of interleukin-2 during homeostasis and activation of the immune system.

Authors:  Onur Boyman; Jonathan Sprent
Journal:  Nat Rev Immunol       Date:  2012-02-17       Impact factor: 53.106

4.  The IL-2/CD25 pathway determines susceptibility to T1D in humans and NOD mice.

Authors:  Calliope A Dendrou; Linda S Wicker
Journal:  J Clin Immunol       Date:  2008-09-09       Impact factor: 8.317

5.  Defects in skin gamma delta T cell function contribute to delayed wound repair in rapamycin-treated mice.

Authors:  Robyn E Mills; Kristen R Taylor; Katie Podshivalova; Dianne B McKay; Julie M Jameson
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

Review 6.  Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy.

Authors:  Wei Liao; Jian-Xin Lin; Warren J Leonard
Journal:  Immunity       Date:  2013-01-24       Impact factor: 31.745

7.  Effector functions of memory CTLs can be affected by signals received during reactivation.

Authors:  Yingjun Lv; Elliot Mattson; Anjuli Bhadurihauck; Karla Garcia; Lei Li; Zhengguo Xiao
Journal:  Immunol Res       Date:  2017-08       Impact factor: 4.505

8.  Cellular mechanisms of restored β-cell tolerance mediated by protective alleles of Idd3 and Idd5.

Authors:  Emma E Hamilton-Williams; Jocelyn Cheung; Daniel B Rainbow; Kara M Hunter; Linda S Wicker; Linda A Sherman
Journal:  Diabetes       Date:  2011-11-21       Impact factor: 9.461

9.  Body-barrier surveillance by epidermal γδ TCRs.

Authors:  Grzegorz Chodaczek; Veena Papanna; M Anna Zal; Tomasz Zal
Journal:  Nat Immunol       Date:  2012-02-12       Impact factor: 25.606

10.  Dendritic cells control CD4+CD25+ Treg cell suppressor function in vitro through juxtacrine delivery of IL-2.

Authors:  Katarina Kulhankova; Todd Rouse; Mohamed E Nasr; Elizabeth H Field
Journal:  PLoS One       Date:  2012-09-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.